NCT06595147 Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study Status RECRUITING Phase NA
NCT06332131 Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature Status ENROLLING_BY_INVITATION Phase N/A
NCT06211413 Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors Status ENROLLING_BY_INVITATION Phase N/A
NCT06060132 Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection Status UNKNOWN Phase N/A
NCT06048458 Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping Status UNKNOWN Phase N/A
NCT06005259 Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Status NOT_YET_RECRUITING Phase PHASE4
NCT05992337 New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity. Status UNKNOWN Phase N/A
NCT05892146 Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05880160 Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05851053 Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study Status RECRUITING Phase N/A
NCT05786014 The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies Status COMPLETED Phase NA
NCT05746598 Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients Status UNKNOWN Phase N/A
NCT05732051 Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients Status RECRUITING Phase PHASE2